These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 32356670)

  • 1. Adherence to national guidelines for colorectal cancer screening in Israel: Comprehensive multi-year assessment based on electronic medical records.
    Paltiel O; Keidar Tirosh A; Paz Stostky O; Calderon-Margalit R; Cohen AD; Elran E; Valinsky L; Matz E; Krieger M; Yehuda AB; Jaffe DH; Manor O
    J Med Screen; 2021 Mar; 28(1):25-33. PubMed ID: 32356670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the patient activation measure associated with adherence to colonoscopy after a positive fecal occult blood test result?
    Azulay R; Valinsky L; Hershkowitz F; Magnezi R
    Isr J Health Policy Res; 2018 Dec; 7(1):74. PubMed ID: 30577883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to completing colonoscopy after a positive fecal occult blood test.
    Azulay R; Valinsky L; Hershkowitz F; Elran E; Lederman N; Kariv R; Braunstein B; Heymann A
    Isr J Health Policy Res; 2021 Feb; 10(1):11. PubMed ID: 33573698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
    Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
    Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial/ethnic and socioeconomic disparities in colorectal cancer screening in a large organization with universal insurance before and during the coronavirus disease 2019 pandemic.
    Levi Z; Abu-Frecha N; Comanesther D; Backenstein T; Cohen AD; Eizenstein S; Flugelman A; Weinstein O
    J Med Screen; 2024 Jun; 31(2):85-90. PubMed ID: 37964557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008.
    Choi KS; Lee HY; Jun JK; Shin A; Park EC
    J Gastroenterol Hepatol; 2012 Jun; 27(6):1070-7. PubMed ID: 22004224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in colonoscopy and fecal occult blood test use after the introduction of dual screening offers in Germany: Results from a large population-based study, 2003-2016.
    Chen C; Stock C; Jansen L; Chang-Claude J; Hoffmeister M; Brenner H
    Prev Med; 2019 Jun; 123():333-340. PubMed ID: 30946858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient randomized trial of a targeted navigation program to improve rates of follow-up colonoscopy in community health centers.
    Coronado GD; Johnson ES; Leo MC; Schneider JL; Smith D; Mummadi R; Petrik AF; Thompson JH; Jimenez R
    Contemp Clin Trials; 2020 Feb; 89():105920. PubMed ID: 31881390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in colorectal cancer screening use after introduction of alternative screening offer in Germany: Prospective cohort study.
    Guo F; Chen C; Schöttker B; Holleczek B; Hoffmeister M; Brenner H
    Int J Cancer; 2020 May; 146(9):2423-2432. PubMed ID: 31291471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Projected Colorectal Cancer Incidence and Mortality Based on Observed Adherence to Colonoscopy and Sequential Stool-Based Screening.
    Meester RGS; Lansdorp-Vogelaar I; Winawer SJ; Church TR; Allen JI; Feld AD; Mills G; Jordan PA; Corley DA; Doubeni CA; Hahn AI; Lobaugh SM; Fleisher M; O'Brien MJ; Zauber AG
    Am J Gastroenterol; 2024 Jul; 119(7):1392-1401. PubMed ID: 38318949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to Competing Strategies for Colorectal Cancer Screening Over 3 Years.
    Liang PS; Wheat CL; Abhat A; Brenner AT; Fagerlin A; Hayward RA; Thomas JP; Vijan S; Inadomi JM
    Am J Gastroenterol; 2016 Jan; 111(1):105-14. PubMed ID: 26526080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Socio-geographical determinants of colonoscopy uptake after faecal occult blood test.
    Dupont-Lucas C; Dejardin O; Dancourt V; Launay L; Launoy G; Guittet L
    Dig Liver Dis; 2011 Sep; 43(9):714-20. PubMed ID: 21530429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial.
    You JJ; Liu Y; Kirby J; Vora P; Moayyedi P
    Trials; 2015 Jul; 16():296. PubMed ID: 26156248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated Automated Mobile Text Messaging Reminders for Follow-Up of Positive Fecal Occult Blood Tests: Randomized Controlled Trial.
    Azulay R; Valinsky L; Hershkowitz F; Magnezi R
    JMIR Mhealth Uhealth; 2019 Feb; 7(2):e11114. PubMed ID: 30720439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients.
    Prince M; Lester L; Chiniwala R; Berger B
    World J Gastroenterol; 2017 Jan; 23(3):464-471. PubMed ID: 28210082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mental Illness Is Not Associated with Adherence to Colorectal Cancer Screening: Results from the California Health Interview Survey.
    Siantz E; Wu B; Shiroishi M; Vora H; Idos G
    Dig Dis Sci; 2017 Jan; 62(1):224-234. PubMed ID: 27822771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do socioeconomic factors play a role in nonadherence to follow-up colonoscopy after a positive faecal immunochemical test in the Flemish colorectal cancer screening programme?
    Hoeck S; van de Veerdonk W; De Brabander I
    Eur J Cancer Prev; 2020 Mar; 29(2):119-126. PubMed ID: 31724969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults.
    Warren Andersen S; Blot WJ; Lipworth L; Steinwandel M; Murff HJ; Zheng W
    JAMA Netw Open; 2019 Dec; 2(12):e1917995. PubMed ID: 31860105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic colonoscopy following a positive fecal occult blood test in community health center patients.
    Liss DT; Brown T; Lee JY; Altergott M; Buchanan DR; Newland A; Park JN; Rittner SS; Baker DW
    Cancer Causes Control; 2016 Jul; 27(7):881-7. PubMed ID: 27228991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.